Dextroamphetamine
| Use attributes for filter ! | |
| Elimination half-life | 9–11 |
|---|---|
| Duration of action | IR dosing: 3–6 hours; XR dosing: 8–12 hours |
| Onset of action | IR dosing: 0. 5–1. 5 hours; XR dosing: 1. 5–2 hours |
| Metabolism | CYP2D6 |
| DBH | |
| FMO3 | |
| Other names | D-Amphetamine |
| Addiction liability | High |
| Dependence liability | Moderate |
| Date of Reg. | |
| Date of Upd. | |
| ID | 3070061 |
About Dextroamphetamine
Dextroamphetamine is a central nervous system stimulant and an amphetamine enantiomer that is prescribed for the treatment of attention deficit hyperactivity disorder and narcolepsy. It is also used as an athletic performance and cognitive enhancer, and recreationally as an aphrodisiac and euphoriant.